Cardiol Therapeutics (TSE:CRDL) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cardiol Therapeutics Inc., a clinical-stage company specializing in heart disease treatments, has announced a public offering of Class A common shares to fund the development of CardiolRx and other company expenses. The final details of the offering will be determined based on market context, with no assurance of completion or the terms of the offering.
For further insights into TSE:CRDL stock, check out TipRanks’ Stock Analysis page.